ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 32 filers reported holding ASLAN PHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $32 | -99.7% | 88,106 | +389.6% | 0.00% | +300.0% |
| Q3 2022 | $11,000 | +22.2% | 17,997 | -0.7% | 0.00% | 0.0% |
| Q2 2022 | $9,000 | -60.9% | 18,119 | -30.6% | 0.00% | -50.0% |
| Q1 2022 | $23,000 | -75.5% | 26,101 | -50.4% | 0.00% | -75.0% |
| Q3 2021 | $94,000 | -54.8% | 52,590 | -15.2% | 0.01% | -46.7% |
| Q1 2021 | $208,000 | +700.0% | 61,997 | +346.2% | 0.02% | +400.0% |
| Q4 2020 | $26,000 | -76.4% | 13,895 | -74.5% | 0.00% | -72.7% |
| Q4 2019 | $110,000 | – | 54,386 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 568,182 | $1,068,181 | 0.12% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |